Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome

Abstract Our aims were to identify factors associated with Pseudomonas aeruginosa (PA) bloodstream infection (BSI) in patients with hematological malignancies and evaluate the outcome of the affected patients. Consecutive patients with hematological malignancies who developed PA BSI were identified....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diagnostic microbiology and infectious disease 2017-08, Vol.88 (4), p.335-341
Hauptverfasser:	Tofas, Polydoros, Samarkos, Michael, Piperaki, Evangelia-Theophano, Kosmidis, Christos, Triantafyllopoulou, Ioanna-Dionysia, Kotsopoulou, Maria, Pantazatou, Aggeliki, Perlorentzou, Stavroula, Poulli, Anastasia, Vagia, Maria, Daikos, George L
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - therapeutic use Bacteremia Bacteremia - drug therapy Bacteremia - microbiology Carbapenems - therapeutic use Case-Control Studies Drug Resistance, Bacterial - drug effects Female Fluoroquinolones - therapeutic use Hematologic malignancy Hematologic Neoplasms - microbiology Hospitalization Humans Infectious Disease Internal Medicine Male Middle Aged Outcome Pseudomonas Pseudomonas aeruginosa - drug effects Pseudomonas Infections - drug therapy Pseudomonas Infections - microbiology Risk Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!